The emerging approach of the medication represents a major development in the care of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatide-peptide343988.elbloglibre.com/42430127/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment